郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Impact of LDL apheresis on atheroprotective reverse cholesterol transport pathway in familial hypercholesterolemia.

期刊：Journal of lipid research发表年份：2012作者：Alexina Orsoni; Elise F Villard; Eric Bruckert; Paul Robillard; Alain Carrie; Dominique Bonnefont-Rousselot; M John Chapman; Geesje M Dallinga-Thie; Wilfried Le Goff; Maryse Guerin
阅读更多 →

药效评价FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality.

期刊：The Journal of clinical investigation发表年份：2012作者：Victoria Shalhoub; Edward M Shatzen; Sabrina C Ward; James Davis; Jennitte Stevens; Vivian Bi; Lisa Renshaw; Nessa Hawkins; Wei Wang; Ching Chen; Mei-Mei Tsai; Russell C Cattley; Thomas J Wronski; Xuechen Xia; Xiaodong Li; Charles Henley; Michael Esc
阅读更多 →

药效评价Structural requirements of membrane phospholipids for M-type potassium channel activation and binding.

期刊：The Journal of biological chemistry发表年份：2012作者：Vsevolod Telezhkin; Joanne M Reilly; Alison M Thomas; Andrew Tinker; David A Brown
阅读更多 →

药效评价Ion channel pharmacology under flow: automation via well-plate microfluidics.

期刊：Assay and drug development technologies发表年份：2012作者：C Ian Spencer; Nianzhen Li; Qin Chen; Juliette Johnson; Tanner Nevill; Juha Kammonen; Cristian Ionescu-Zanetti
阅读更多 →